☰

Teodora I. Kaltcheva, Ph.D.

Affiliations: 
2009 Chemistry University of Southern California, Los Angeles, CA, United States 
Area:
Organic Light Emitting Diodes, Organic PhotoVoltaic Devices, Development of Nano-Biotic Sensors, Development of Abiotic-Biotic Interfaces
Google:
"Teodora Kaltcheva"
Mean distance: 8.47
 		SNBCP
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Mark Edward Thompson grad student 2009 USC
 (Chemical probes for imaging biological processes.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yll-Pico M, Park Y, Martinez J, et al. (2024) Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platform. Npj Vaccines. 9: 68
Chiuppesi F, Ortega-Francisco S, Gutierrez MA, et al. (2023) Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy. Vaccines. 11
La Rosa C, Chiuppesi F, Park Y, et al. (2023) Functional SARS-CoV-2-specific T cells of donor origin in allogeneic stem cell transplant recipients of a T-cell-replete infusion: A prospective observational study. Frontiers in Immunology. 14: 1114131
La Rosa C, Aldoss I, Park Y, et al. (2023) Hematopoietic stem cell donor vaccination with CMV Triplex augments frequencies of functional and durable CMV-specific T cells in the recipient: a novel strategy to limit antiviral prophylaxis. American Journal of Hematology
Chiuppesi F, Zaia JA, Faircloth K, et al. (2022) Vaccine-induced spike- and nucleocapsid-specific cellular responses maintain potent cross-reactivity to SARS-CoV-2 Delta and Omicron variants. Iscience. 104745
Chiuppesi F, Nguyen VH, Park Y, et al. (2022) Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates. Npj Vaccines. 7: 7
Pourhassan H, LA Rosa C, Chiuppesi F, et al. (2022) Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity. Blood Advances
Chiuppesi F, Nguyen VH, Park Y, et al. (2021) Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates. Biorxiv : the Preprint Server For Biology
Chiuppesi F, Salazar MD, Contreras H, et al. (2020) Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform. Nature Communications. 11: 6121
Chiuppesi F, Salazar MDA, Contreras H, et al. (2020) Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform. Research Square
See more...